ITGB5 and in situ carcinoma: We found that many proteins participating in the EMT and immune, which are JUN target genes (TG), were upregulated in CIS (Fig. 4h and Supplementary Fig. 4g), such as SERPINA3, ITGB5, and VCAM1.